News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Myeloma Paper of the Day, July 16th, Suggested by Robert Orlowski
Jul 16, 2025, 09:27

Myeloma Paper of the Day, July 16th, Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day:

Genomic and immune profiling of prognostic groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P e.g. CXCR4, KMT2D, ARID1A and EP300 mutations, upregulated genes involved in NF-κB and BCR signaling activation.”

Title: Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P

Authors: David F. Moreno, Ferran Nadeu, Fara Brasó-Maristany, Sergi Vaqué, Sara Paz, Joan Mañé, Oriol Cardús, Elena Medina, Ester Lozano, Luis Gerardo Rodríguez-Lobato, Anna de Daniel, Natalia Tovar, María T. Cibeira, Joan Bladé, Laura Rosiñol, Aleix Prat, Dolors Colomer, Carlos Fernández de Larrea.

You can read the Full Article in Frontiers in Immunology.

Myeloma Paper of the Day, July 16th, Suggested by Robert Orlowski

You can find more posts featuring Robert Orlowski in OncoDaily.

Aleix Prat Anna de Daniel cancer Carlos Fernández de Larrea David F. Moreno Dolors Colomer Elena Medina Ester Lozano Fara Brasó-Maristany Ferran Nadeu IgM gammopathy Joan Bladé Joan Mañé Laura Rosiñol Luis Gerardo Rodríguez-Lobato María T. Cibeira Myeloma Myeloma Paper of the Day Natalia Tovar OncoDaily Oncology Oriol Cardús Robert Orlowski Sara Paz Sergi Vaqué
Special Coverage
Science
Jul 16, 2025, 09:27
Myeloma Paper of the Day, July 16th, Suggested by Robert Orlowski
Oncolibrary
Jul 16, 2025, 09:22
TOP Immunotherapy trials from ESMO GI 2025
Insight
Jul 16, 2025, 09:06
Glioblastoma Awareness Day 2025: Uniting for Progress and Hope
Oncolibrary
Jul 16, 2025, 08:58
New Paper Alert: Zanidatamab Plus Chemotherapy for HER2-Positive Gastro-Oesophageal Adenocarcinoma
Blog
Jul 16, 2025, 08:57
Celia Diez de los Rios: The GoodDay Project Invites Glioblastoma Patients to Share What Makes a Good Day
Oncolibrary
Jul 16, 2025, 08:55
Tabelecleucel (Ebvallo) FDA Update: CRL Issued Despite Positive Phase 3 ALLELE Trial Results
Blog
Jul 16, 2025, 08:51
Submit an abstract by July 23 for the AACR Special Conference on Mechanisms of Cancer Immunity and Cancer-related Autoimmunity
Blog
Jul 16, 2025, 08:43
Glioblastoma Awareness Day - WeTrials
Blog
Jul 16, 2025, 08:39
Don’t Miss Your Chance to Be Part of the Very First CCI President’s Recognition Awards
Oncolibrary
Jul 16, 2025, 08:27
Adjuvant Therapy in Cancer: Benefits, Types, Timing, and Precision-Based Innovations
Insight
Jul 16, 2025, 07:52
Corinne Faivre-Finn: How pragmatic clinical trials can bring research closer to everyday care
Blog
Jul 16, 2025, 07:32
Angela Mastronuzzi: Glioblastoma Awareness Day - Support research. Honor the fighters